Amylyx Pharmaceuticals, Inc. (AMLX)

Amylyx Pharmaceuticals Statistics

Total Valuation

AMLX has a market cap or net worth of $314.98 million. The enterprise value is $149.77 million.

Market Cap	314.98M
Enterprise Value	149.77M

Important Dates

The last earnings date was Tuesday, March 4, 2025, before market open.

Earnings Date	Mar 4, 2025
Ex-Dividend Date	n/a

Share Statistics

AMLX has 88.60 million shares outstanding. The number of shares has decreased by -2.64% in one year.

Current Share Class	88.60M
Shares Outstanding	88.60M
Shares Change (YoY)	-2.64%
Shares Change (QoQ)	+0.74%
Owned by Insiders (%)	7.90%
Owned by Institutions (%)	48.36%
Float	59.47M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.85
Forward PS	n/a
PB Ratio	1.52
P/TBV Ratio	1.97
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	1.71
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.67, with a Debt / Equity ratio of 0.01.

Current Ratio	6.67
Quick Ratio	6.23
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -100.88% and return on invested capital (ROIC) is -60.36%.

Return on Equity (ROE)	-100.88%
Return on Assets (ROA)	-51.31%
Return on Invested Capital (ROIC)	-60.36%
Return on Capital Employed (ROCE)	-176.65%
Revenue Per Employee	$710,333
Profits Per Employee	-$2.45M
Employee Count	123
Asset Turnover	0.25
Inventory Turnover	n/a

Taxes

Income Tax	-393,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +27.08% in the last 52 weeks. The beta is -0.51, so AMLX's price volatility has been lower than the market average.

Beta (5Y)	-0.51
52-Week Price Change	+27.08%
50-Day Moving Average	3.54
200-Day Moving Average	3.39
Relative Strength Index (RSI)	50.66
Average Volume (20 Days)	834,400

Short Selling Information

The latest short interest is 3.75 million, so 4.23% of the outstanding shares have been sold short.

Short Interest	3.75M
Short Previous Month	3.65M
Short % of Shares Out	4.23%
Short % of Float	6.30%
Short Ratio (days to cover)	4.64

Income Statement

In the last 12 months, AMLX had revenue of $87.37 million and -$301.74 million in losses. Loss per share was -$4.43.

Revenue	87.37M
Gross Profit	-141.35M
Operating Income	-291.88M
Pretax Income	-162.36M
Net Income	-301.74M
EBITDA	-290.98M
EBIT	-291.88M
Loss Per Share	-$4.43

Balance Sheet

The company has $176.50 million in cash and $1.98 million in debt, giving a net cash position of $174.52 million or $1.97 per share.

Cash & Cash Equivalents	176.50M
Total Debt	1.98M
Net Cash	174.52M
Net Cash Per Share	$1.97
Equity (Book Value)	164.77M
Book Value Per Share	2.40
Working Capital	161.03M

Cash Flow

In the last 12 months, operating cash flow was -$167.65 million and capital expenditures -$36.36 million, giving a free cash flow of -$204.01 million.

Operating Cash Flow	-167.65M
Capital Expenditures	-36.36M
Free Cash Flow	-204.01M
FCF Per Share	-$2.30

Margins

Gross Margin	-161.78%
Operating Margin	-334.07%
Pretax Margin	-345.81%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

AMLX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	2.64%
Shareholder Yield	n/a
Earnings Yield	-93.05%
FCF Yield	-62.91%

Analyst Forecast

The average price target for AMLX is $7.50, which is 110.97% higher than the current price. The consensus rating is "Buy".

Price Target	$7.50
Price Target Difference	110.97%
Analyst Consensus	Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	11.00%
EPS Growth Forecast (5Y)	-25.45%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

AMLX has an Altman Z-Score of -0.28 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.28
Piotroski F-Score	2